{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:30:24Z","timestamp":1793316624183,"version":"4.5.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/1673-5374.360164","type":"journal-article","created":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T02:36:17Z","timestamp":1669430177000},"page":"1179","source":"Crossref","is-referenced-by-count":32,"title":["Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review"],"prefix":"10.4103","volume":"18","author":[{"given":"Muzaimi","family":"Mustapha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NorlinahMohamed","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah","family":"Hui Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrul","family":"Azmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Makpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HanafiAhmad","family":"Damanhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JemaimaChe","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.360164-1","doi-asserted-by":"crossref","unstructured":"Assoni G, Frapporti G, Colombo E, Gornati D, Perez-Carrion MD, Polito L, Seneci P, Piccoli G, Arosio D (2021) Trehalose-based neuroprotective autophagy inducers. Bioorg Med Chem Lett. 40:127929.","DOI":"10.1016\/j.bmcl.2021.127929"},{"key":"key-10.4103\/1673-5374.360164-2","doi-asserted-by":"crossref","unstructured":"Bebarta V, Luyten D, Heard K (2003) Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med 10:684-687.","DOI":"10.1111\/j.1553-2712.2003.tb00056.x"},{"key":"key-10.4103\/1673-5374.360164-3","doi-asserted-by":"crossref","unstructured":"Bello S, Krogsb\u00f8ll LT, Gruber J, Zhao ZJ, Fischer D, Hr\u00f3bjartsson A (2014) Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias. J Clin Epidemiol. 67:973-983.","DOI":"10.1016\/j.jclinepi.2014.04.008"},{"key":"key-10.4103\/1673-5374.360164-4","doi-asserted-by":"crossref","unstructured":"Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, Mari\u00ebn P, Nowak DA, Schmahmann JD, Serrao M (2016) Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum 15:369-391.","DOI":"10.1007\/s12311-015-0687-3"},{"key":"key-10.4103\/1673-5374.360164-5","doi-asserted-by":"crossref","unstructured":"Cabezas R, \u00c1vila M, Gonzalez J, El-Bach\u00e1 RS, B\u00e1ez E, Garc\u00eda-Segura LM, Jurado Coronel JC, Capani F, Cardona-Gomez GP, Barreto GE (2014) Astrocytic modulation of blood brain barrier: Perspectives on Parkinson\u2019s disease. Front Cell Neurosci 8:211.","DOI":"10.3389\/fncel.2014.00211"},{"key":"key-10.4103\/1673-5374.360164-6","doi-asserted-by":"crossref","unstructured":"Castillo K, Nassif M, Valenzuela V, Rojas F, Matus S, Mercado G, Court FA, van Zundert B, Hetz C (2013) Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9:1308-1320.","DOI":"10.4161\/auto.25188"},{"key":"key-10.4103\/1673-5374.360164-7","doi-asserted-by":"crossref","unstructured":"Chen ZZ, Wang CM, Lee GC, Hsu HC, Wu TL, Lin CW, Ma CK, Lee-Chen GJ, Huang HJ, Hsieh-Li HM (2015) Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice. Neurochem Res 40:800-810.","DOI":"10.1007\/s11064-015-1530-4"},{"key":"key-10.4103\/1673-5374.360164-8","doi-asserted-by":"crossref","unstructured":"Cummings J (2017) Disease modification and neuroprotection in neurodegenerative disorders. Transl Neurodegener 6:25-31.","DOI":"10.1186\/s40035-017-0096-2"},{"key":"key-10.4103\/1673-5374.360164-9","unstructured":"Darabi S, Noori-Zadeh A, Abbaszadeh H-A, Rajaei F, Bakhtiyari S (2019) Trehalose neuroprotective effects on the substantia nigra dopaminergic cells by activating autophagy and non-canonical Nrf2 pathways. Iran J Pharm Res 18:1419-1428."},{"key":"key-10.4103\/1673-5374.360164-10","unstructured":"de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD (1997) The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 49:143-156."},{"key":"key-10.4103\/1673-5374.360164-11","doi-asserted-by":"crossref","unstructured":"Debnath K, Pradhan N, Singh BK, Jana NR, Jana NR (2017) Poly (trehalose) nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington\u2019s disease model mouse. ACS Appl Mater Interfaces 9:24126-24139.","DOI":"10.1021\/acsami.7b06510"},{"key":"key-10.4103\/1673-5374.360164-12","doi-asserted-by":"crossref","unstructured":"Debnath K, Pradhan N, Singh BK, Jana NR, Jana NR (2019) Correction to poly (trehalose) nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington\u2019s disease model mouse. ACS Appl Mater Interfaces 11:30508-30508.","DOI":"10.1021\/acsami.9b12769"},{"key":"key-10.4103\/1673-5374.360164-13","doi-asserted-by":"crossref","unstructured":"Delenclos M, Burgess JD, Lamprokostopoulou A, Outeiro TF, Vekrellis K, McLean PJ (2019) Cellular models of alpha-synuclein toxicity and aggregation. J Neurochem. 150:566-576.","DOI":"10.1111\/jnc.14806"},{"key":"key-10.4103\/1673-5374.360164-14","doi-asserted-by":"crossref","unstructured":"Du J, Liang Y, Xu F, Sun B, Wang Z (2013) Trehalose rescues A lzheimer\u2019s disease phenotypes in APP\/PS 1 transgenic mice. J Pharm Pharmacol 65:1753-1756.","DOI":"10.1111\/jphp.12108"},{"key":"key-10.4103\/1673-5374.360164-15","doi-asserted-by":"crossref","unstructured":"Eichenbaum H (2017) The role of the hippocampus in navigation is memory. J Neurophysiol 117:1785-1796.","DOI":"10.1152\/jn.00005.2017"},{"key":"key-10.4103\/1673-5374.360164-16","doi-asserted-by":"crossref","unstructured":"Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E (2012) Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322:254-262.","DOI":"10.1016\/j.jns.2012.05.030"},{"key":"key-10.4103\/1673-5374.360164-17","doi-asserted-by":"crossref","unstructured":"Felice VD, Quigley EM, Sullivan AM, O\u2019Keeffe GW, O\u2019Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson\u2019s disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27:1-8.","DOI":"10.1016\/j.parkreldis.2016.03.012"},{"key":"key-10.4103\/1673-5374.360164-18","doi-asserted-by":"crossref","unstructured":"Ferguson SA, Law CD, Sarkar S (2015) Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment. Behav Brain Res 292:68-78.","DOI":"10.1016\/j.bbr.2015.05.057"},{"key":"key-10.4103\/1673-5374.360164-19","doi-asserted-by":"crossref","unstructured":"Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, Mart\u00edn-Segura A, Puri C, Scrivo A, Skidmore J (2022) The different autophagy degradation pathways and neurodegeneration. Neuron 110:935-966.","DOI":"10.1016\/j.neuron.2022.01.017"},{"key":"key-10.4103\/1673-5374.360164-20","doi-asserted-by":"crossref","unstructured":"Furcila D, DeFelipe J, Alonso-Nanclares L (2018) A study of amyloid-\u03b2 and phosphotau in plaques and neurons in the hippocampus of Alzheimer\u2019s disease patients. J Alzheimers Dis 64:417-435.","DOI":"10.3233\/JAD-180173"},{"key":"key-10.4103\/1673-5374.360164-21","doi-asserted-by":"crossref","unstructured":"Goedert M, Spillantini MG (2017) Propagation of tau aggregates. Mol Brain 10:18.","DOI":"10.1186\/s13041-017-0298-7"},{"key":"key-10.4103\/1673-5374.360164-22","doi-asserted-by":"crossref","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, Van Den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:1-19.","DOI":"10.1038\/nrdp.2017.71"},{"key":"key-10.4103\/1673-5374.360164-23","doi-asserted-by":"crossref","unstructured":"He Q, Koprich JB, Wang Y, Yu WB, Xiao BG, Brotchie JM, Wang J (2016) Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV \u03b1-synuclein rat model of Parkinson\u2019s disease. Mol Neurobiol 53:2258-2268.","DOI":"10.1007\/s12035-015-9173-7"},{"key":"key-10.4103\/1673-5374.360164-24","doi-asserted-by":"crossref","unstructured":"Holler CJ, Taylor G, McEachin ZT, Deng Q, Watkins WJ, Hudson K, Easley CA, Hu WT, Hales CM, Rossoll W (2016) Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: A novel therapeutic lead to treat frontotemporal dementia. Mol Neurodegener 11:46.","DOI":"10.1186\/s13024-016-0114-3"},{"key":"key-10.4103\/1673-5374.360164-25","doi-asserted-by":"crossref","unstructured":"Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43.","DOI":"10.1186\/1471-2288-14-43"},{"key":"key-10.4103\/1673-5374.360164-26","doi-asserted-by":"crossref","unstructured":"Howson PA, Johnston TH, Ravenscroft P, Hill MP, Su J, Brotchie JM, Koprich JB (2019) Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson\u2019s disease. J Pharmacol Exp Ther 369:364-374.","DOI":"10.1124\/jpet.118.255695"},{"key":"key-10.4103\/1673-5374.360164-27","doi-asserted-by":"crossref","unstructured":"Hussain R, Zubair H, Pursell S, Shahab M (2018) Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches. Brain Sci 8:177.","DOI":"10.3390\/brainsci8090177"},{"key":"key-10.4103\/1673-5374.360164-28","doi-asserted-by":"crossref","unstructured":"Im JK, Kim SJ, Jeong YH, Kim WI, Lee DH, Lee WS, Chang YT, Kim KT, Chung SK (2013) Preparation and evaluation of BBB-permeable trehalose derivatives as potential therapeutic agents for Huntington\u2019s disease. Med Chem Comm 4:310-316.","DOI":"10.1039\/C2MD20112G"},{"key":"key-10.4103\/1673-5374.360164-29","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2007) More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains. Acta Neuropathologica 114:299-303.","DOI":"10.1007\/s00401-007-0227-4"},{"key":"key-10.4103\/1673-5374.360164-30","unstructured":"Junod S (2013) FDA and clinical drug trials: a short history. In: A quick guide to clinical trials (Davies M and Kerimani F, eds), pp. 25-55. Washington: Bioplan, Inc."},{"key":"key-10.4103\/1673-5374.360164-31","doi-asserted-by":"crossref","unstructured":"Kakoty V, KC S, Dubey SK, Yang CH, Taliyan R (2021) Neuroprotective effects of trehalose and sodium butyrate on preformed fibrillar form of \u03b1-synuclein-induced rat model of Parkinson\u2019s disease. ACS Chem Neurosci 12:2643-2660.","DOI":"10.1021\/acschemneuro.1c00144"},{"key":"key-10.4103\/1673-5374.360164-32","doi-asserted-by":"crossref","unstructured":"Kashon ML, Ross GW, O\u2019Callaghan JP, Miller DB, Petrovitch H, Burchfiel CM, Sharp DS, Markesbery WR, Davis DG, Hardman J (2004) Associations of cortical astrogliosis with cognitive performance and dementia status. J Alzheimers Dis 6:595-604.","DOI":"10.3233\/JAD-2004-6604"},{"key":"key-10.4103\/1673-5374.360164-33","doi-asserted-by":"crossref","unstructured":"Khalifeh M, Barreto GE, Sahebkar A (2021) Therapeutic potential of trehalose in neurodegenerative diseases: The knowns and unknowns. Neural Regen Res 16:2026.","DOI":"10.4103\/1673-5374.308085"},{"key":"key-10.4103\/1673-5374.360164-34","doi-asserted-by":"crossref","unstructured":"Khangwal I, Shukla P (2019) Potential prebiotics and their transmission mechanisms: Recent approaches. J Food Drug Anal 27:649-656.","DOI":"10.1016\/j.jfda.2019.02.003"},{"key":"key-10.4103\/1673-5374.360164-35","doi-asserted-by":"crossref","unstructured":"Lee HJ, Yoon YS, Lee SJ (2018) Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction. Cell Death Dis. 9:712.","DOI":"10.1038\/s41419-018-0749-9"},{"key":"key-10.4103\/1673-5374.360164-36","doi-asserted-by":"crossref","unstructured":"Lee JM, Correia K, Loupe J, Kim KH, Barker D, Hong EP, Chao MJ, Long JD, Lucente D, Vonsattel JPG (2019) CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178:887-900. e814.","DOI":"10.1016\/j.cell.2019.06.036"},{"key":"key-10.4103\/1673-5374.360164-37","first-page":"2422","article-title":"J Agric Food Chem","author":"Lee","year":"2021","journal-title":""},{"key":"key-10.4103\/1673-5374.360164-38","doi-asserted-by":"crossref","unstructured":"Li KY, Li JT, Zheng JL, Qin S (2019) Reactive astrocytes in neurodegenerative diseases. Aging Dis 10:664.","DOI":"10.14336\/AD.2018.0720"},{"key":"key-10.4103\/1673-5374.360164-39","doi-asserted-by":"crossref","unstructured":"Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H, Li C (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience 298:12-25.","DOI":"10.1016\/j.neuroscience.2015.03.061"},{"key":"key-10.4103\/1673-5374.360164-40","doi-asserted-by":"crossref","unstructured":"Lieberman AP, Shakkottai VG, Albin RL (2019) Polyglutamine repeats in neurodegenerative diseases. Annu Rev Pathol 14:1-27.","DOI":"10.1146\/annurev-pathmechdis-012418-012857"},{"key":"key-10.4103\/1673-5374.360164-41","doi-asserted-by":"crossref","unstructured":"Lin CH, Wei PC, Chen CM, Huang YT, Lin JL, Lo YS, Lin JL, Lin CY, Wu YR, Chang KH (2020) Lactulose and melibiose attenuate MPTP-induced Parkinson\u2019s disease in mice by inhibition of oxidative stress, reduction of neuroinflammation and up-regulation of autophagy. Front Aging Neurosci 12:226.","DOI":"10.3389\/fnagi.2020.00226"},{"key":"key-10.4103\/1673-5374.360164-42","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang J, Hsiung GR, Song W (2020) Trehalose inhibits A\u03b2 generation and plaque formation in Alzheimer\u2019s disease. Mol Neurobiol 57:3150-3157.","DOI":"10.1007\/s12035-020-01942-1"},{"key":"key-10.4103\/1673-5374.360164-43","doi-asserted-by":"crossref","unstructured":"Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler JP, Mead R, Niessen HG, Petri S, Pradat PF (2010) Guidelines for preclinical animal research in ALS\/MND: A consensus meeting. Amyotroph Lateral Scler 11:38-45.","DOI":"10.3109\/17482960903545334"},{"key":"key-10.4103\/1673-5374.360164-44","doi-asserted-by":"crossref","unstructured":"Mayer AL, Higgins CB, Heitmeier MR, Kraft TE, Qian X, Crowley JR, Hyrc KL, Beatty WL, Yarasheski KE, Hruz PW (2016) SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci Rep 6:1-15.","DOI":"10.1038\/srep38586"},{"key":"key-10.4103\/1673-5374.360164-45","doi-asserted-by":"crossref","unstructured":"McCann H, Stevens CH, Cartwright H, Halliday GM (2014) \u03b1-Synucleinopathy phenotypes. Parkinsonism Relat Disord 20:S62-S67.","DOI":"10.1016\/S1353-8020(13)70017-8"},{"key":"key-10.4103\/1673-5374.360164-46","doi-asserted-by":"crossref","unstructured":"Minami SS, Min SW, Krabbe G, Wang C, Zhou YG, Asgarov R, Li YQ, Martens LH, Elia LP, Ward ME (2014) Progranulin protects against amyloid \u03b2 deposition and toxicity in Alzheimer\u2019s disease mouse models. Nat Med 20:1157-1164.","DOI":"10.1038\/nm.3672"},{"key":"key-10.4103\/1673-5374.360164-47","doi-asserted-by":"crossref","unstructured":"Mizunoe Y, Kobayashi M, Sudo Y, Watanabe S, Yasukawa H, Natori D, Hoshino A, Negishi A, Okita N, Komatsu M (2018) Trehalose protects against oxidative stress by regulating the Keap1\u2013Nrf2 and autophagy pathways. Redox Biol 15:115-124.","DOI":"10.1016\/j.redox.2017.09.007"},{"key":"key-10.4103\/1673-5374.360164-48","doi-asserted-by":"crossref","unstructured":"Moon SH, Kwon Y, Huh YE, Choi HJ (2022) Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson\u2019s disease. Arch Pharm Res 45: 417-432.","DOI":"10.1007\/s12272-022-01386-2"},{"key":"key-10.4103\/1673-5374.360164-49","doi-asserted-by":"crossref","unstructured":"Moussaud S, Jones DR, Moussaud-Lamodi\u00e8re EL, Delenclos M, Ross OA, McLean PJ (2014) Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegener 9:43.","DOI":"10.1186\/1750-1326-9-43"},{"key":"key-10.4103\/1673-5374.360164-50","doi-asserted-by":"crossref","unstructured":"Narita H, Tanji K, Miki Y, Mori F, Wakabayashi K (2019) Trehalose intake and exercise upregulate a glucose transporter, GLUT8, in the brain. Biochem Biophys Res Commun 514:672-677.","DOI":"10.1016\/j.bbrc.2019.05.017"},{"key":"key-10.4103\/1673-5374.360164-51","doi-asserted-by":"crossref","unstructured":"Noorasyikin M, Elena A, Teh P, Waheeda TF, Hajar MS, Long K, Norlinah M (2020) Oral trehalose maybe helpful for patients with spinocerebellar ataxia 3 and should be better evaluated. Parkinsonism Relat Disord 70:42-44.","DOI":"10.1016\/j.parkreldis.2019.12.007"},{"key":"key-10.4103\/1673-5374.360164-52","doi-asserted-by":"crossref","unstructured":"Olsson C, Jansson Hn, Swenson J (2016) The role of trehalose for the stabilization of proteins. J Phys Chem B 120:4723-4731.","DOI":"10.1021\/acs.jpcb.6b02517"},{"key":"key-10.4103\/1673-5374.360164-53","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"key-10.4103\/1673-5374.360164-54","doi-asserted-by":"crossref","unstructured":"Patching SG (2017) Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery. Mol Neurobiol 54:1046-1077.","DOI":"10.1007\/s12035-015-9672-6"},{"key":"key-10.4103\/1673-5374.360164-55","doi-asserted-by":"crossref","unstructured":"Perucho J, Casarejos MJ, Gomez A, Solano RM, de Y\u00e9benes JG, Mena MA (2012) Trehalose protects from aggravation of amyloid pathology induced by isoflurane anesthesia in APP(swe) mutant mice. Curr Alzheimer Res 9:334-343.","DOI":"10.2174\/156720512800107573"},{"key":"key-10.4103\/1673-5374.360164-56","doi-asserted-by":"crossref","unstructured":"Portbury SD, Hare DJ, Sgambelloni C, Perronnes K, Portbury AJ, Finkelstein DI, Adlard PA (2017) Trehalose improves cognition in the transgenic Tg2576 mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 60:549-560.","DOI":"10.3233\/JAD-170322"},{"key":"key-10.4103\/1673-5374.360164-57","doi-asserted-by":"crossref","unstructured":"Pupyshev A, Tenditnik M, Ovsyukova M, Akopyan A, Dubrovina N, Tikhonova M (2021) Restoration of Parkinson\u2019s disease-like deficits by activating autophagy through mTOR-dependent and mTOR-independent mechanisms in pharmacological and transgenic models of Parkinson\u2019s disease in mice. Bull Exp Biol Med 171:425-430.","DOI":"10.1007\/s10517-021-05242-z"},{"key":"key-10.4103\/1673-5374.360164-58","doi-asserted-by":"crossref","unstructured":"Pupyshev AB, Tikhonova MA, Akopyan AA, Tenditnik MV, Dubrovina NI, Korolenko TA (2019) Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson\u2019s disease. Pharmacol Biochem Behav 177:1-11.","DOI":"10.1016\/j.pbb.2018.12.005"},{"key":"key-10.4103\/1673-5374.360164-59","doi-asserted-by":"crossref","unstructured":"Pupyshev AB, Belichenko VM, Tenditnik MV, Bashirzade AA, Dubrovina NI, Ovsyukova MV, Akopyan AA, Fedoseeva LA, Korolenko TA, Amstislavskaya TG (2022) Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer\u2019s disease-like pathology in a mouse model. Pharmacol Biochem Behav 217:173406.","DOI":"10.1016\/j.pbb.2022.173406"},{"key":"key-10.4103\/1673-5374.360164-60","doi-asserted-by":"crossref","unstructured":"Reagan LP, Rosell DR, Alves SE, Hoskin EK, McCall AL, Charron MJ, McEwen BS (2002) GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus. Brain Res 932:129-134.","DOI":"10.1016\/S0006-8993(02)02308-9"},{"key":"key-10.4103\/1673-5374.360164-61","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Navarro JA, Rodr\u00edguez L, Casarejos MJ, Solano RM, G\u00f3mez A, Perucho J, Cuervo AM, de Y\u00e9benes JG, Mena MA (2010) Trehalose ameliorates dopaminergic and tau pathology in parkin deleted\/tau overexpressing mice through autophagy activation. Neurobiol Dis 39:423-438.","DOI":"10.1016\/j.nbd.2010.05.014"},{"key":"key-10.4103\/1673-5374.360164-62","doi-asserted-by":"crossref","unstructured":"Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780-786.","DOI":"10.1038\/nature05291"},{"key":"key-10.4103\/1673-5374.360164-63","doi-asserted-by":"crossref","unstructured":"Rusmini P, Cortese K, Crippa V, Cristofani R, Cicardi ME, Ferrari V, Vezzoli G, Tedesco B, Meroni M, Messi E (2019) Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy 15:631-651.","DOI":"10.1080\/15548627.2018.1535292"},{"key":"key-10.4103\/1673-5374.360164-64","doi-asserted-by":"crossref","unstructured":"Santana MM, Paix\u00e3o S, Cunha-Santos J, Silva TP, Trevino-Garcia A, Gaspar LS, N\u00f3brega C, Nobre RJ, Cavadas C, Greif H (2020) Trehalose alleviates the phenotype of Machado\u2013Joseph disease mouse models. J Transl Med 18:161.","DOI":"10.1186\/s12967-020-02302-2"},{"key":"key-10.4103\/1673-5374.360164-65","doi-asserted-by":"crossref","unstructured":"Sarkar S, Chigurupati S, Raymick J, Mann D, Bowyer JF, Schmitt T, Beger RD, Hanig JP, Schmued LC, Paule MG (2014) Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson\u2019s disease mouse model. Neurotoxicology 44:250-262.","DOI":"10.1016\/j.neuro.2014.07.006"},{"key":"key-10.4103\/1673-5374.360164-66","doi-asserted-by":"crossref","unstructured":"Schaeffer V, Goedert M (2012) Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy 8:1686-1687.","DOI":"10.4161\/auto.21488"},{"key":"key-10.4103\/1673-5374.360164-67","doi-asserted-by":"crossref","unstructured":"Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M (2012) Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 135:2169-2177.","DOI":"10.1093\/brain\/aws143"},{"key":"key-10.4103\/1673-5374.360164-68","doi-asserted-by":"crossref","unstructured":"Shao J, Diamond MI (2007) Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet 16:R115-123.","DOI":"10.1093\/hmg\/ddm213"},{"key":"key-10.4103\/1673-5374.360164-69","doi-asserted-by":"crossref","unstructured":"Shohayeb B, Diab M, Ahmed M, Ng DCH (2018) Factors that influence adult neurogenesis as potential therapy. Transl Neurodegener 7:4.","DOI":"10.1186\/s40035-018-0109-9"},{"key":"key-10.4103\/1673-5374.360164-70","doi-asserted-by":"crossref","unstructured":"Takahashi T, Katada S, Onodera O (2010) Polyglutamine diseases: Where does toxicity come from? What is toxicity? Where are we going? J Mol Cell Biol 2:180-191.","DOI":"10.1093\/jmcb\/mjq005"},{"key":"key-10.4103\/1673-5374.360164-71","doi-asserted-by":"crossref","unstructured":"Takata K (1996) Glucose transporters in the transepithelial transport of glucose. Microscopy 45:275-284.","DOI":"10.1093\/oxfordjournals.jmicro.a023443"},{"key":"key-10.4103\/1673-5374.360164-72","doi-asserted-by":"crossref","unstructured":"Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10:148-154.","DOI":"10.1038\/nm985"},{"key":"key-10.4103\/1673-5374.360164-73","doi-asserted-by":"crossref","unstructured":"Tanji K, Miki Y, Maruyama A, Mimura J, Matsumiya T, Mori F, Imaizumi T, Itoh K, Wakabayashi K (2015) Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease. Biochem Biophys Res Commun 465:746-752.","DOI":"10.1016\/j.bbrc.2015.08.076"},{"key":"key-10.4103\/1673-5374.360164-74","doi-asserted-by":"crossref","unstructured":"Uddin M, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, Bergantin LB, Abdel-Daim MM, Stankiewicz AM (2018) Autophagy and Alzheimer\u2019s disease: From molecular mechanisms to therapeutic implications. Front Aging Neurosci 10:4.","DOI":"10.3389\/fnagi.2018.00004"},{"key":"key-10.4103\/1673-5374.360164-75","doi-asserted-by":"crossref","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:22-35.","DOI":"10.1038\/nrn.2015.1"},{"key":"key-10.4103\/1673-5374.360164-76","doi-asserted-by":"crossref","unstructured":"Yang CR, Yu RK (2009) Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington\u2019s disease. J Neurosci Res 87:26-33.","DOI":"10.1002\/jnr.21817"},{"key":"key-10.4103\/1673-5374.360164-77","doi-asserted-by":"crossref","unstructured":"Yoon YS, Cho E-D, Ahn WJ, Lee KW, Lee SJ, Lee HJ (2017) Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation. Cell Death Dis 8:e3091.","DOI":"10.1038\/cddis.2017.501"},{"key":"key-10.4103\/1673-5374.360164-78","doi-asserted-by":"crossref","unstructured":"Zaltzman R, Elyoseph Z, Lev N, Gordon CR (2020) Trehalose in Machado-Joseph disease: Safety, tolerability, and efficacy. The Cerebellum 19:672-679.","DOI":"10.1007\/s12311-020-01150-6"},{"key":"key-10.4103\/1673-5374.360164-79","doi-asserted-by":"crossref","unstructured":"Zhai S, Tanimura A, Graves SM, Shen W, Surmeier DJ (2018) Striatal synapses, circuits, and Parkinson\u2019s disease. Curr Opin Neurobiol 48:9-16.","DOI":"10.1016\/j.conb.2017.08.004"},{"key":"key-10.4103\/1673-5374.360164-80","doi-asserted-by":"crossref","unstructured":"Zhang XJ, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W (2014) MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 10:588-602.","DOI":"10.4161\/auto.27710"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:41:08Z","timestamp":1787164868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.360164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"alternative-id":["360164"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.360164","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}